U.S. Packaging Stock News

NYSE:ADNT
NYSE:ADNTAuto Components

Adient (ADNT) Valuation Check As Sculpted Soft Trim Targets Seat Design And Efficiency

Adient (ADNT) has drawn fresh attention after introducing Sculpted Soft Trim, a new seat trim product aimed at improving vehicle interior design, cutting sewing labor, and simplifying complex shapes for automaker customers. See our latest analysis for Adient. The Sculpted Soft Trim launch comes as Adient’s share price sits at US$24.79, with a 30 day share price return of 16.06% and a year to date share price return of 30.20%. This points to building momentum despite a 3 year total shareholder...
NYSEAM:INFU
NYSEAM:INFUHealthcare

InfuSystem Holdings (INFU) Margin Gains Reinforce Bullish Narrative Despite Modest Revenue Growth

InfuSystem Holdings (INFU) has wrapped up FY 2025 with Q4 revenue of US$36.2 million and basic EPS of US$0.10, capping a year in which trailing twelve month revenue reached US$143.4 million and EPS came in at US$0.32. The company has seen quarterly revenue move from US$33.8 million in Q4 2024 to US$36.5 million in Q3 2025 and US$36.2 million in Q4 2025, while basic EPS shifted from US$0.04 in Q4 2024 through a low of US$0.01 loss in Q1 2025 before landing between US$0.10 and US$0.12 over the...
NYSE:YOU
NYSE:YOUSoftware

Clear Secure (YOU) Margin Compression Tests Bullish Earnings Narratives After FY 2025 Results

Clear Secure FY 2025 earnings snapshot Clear Secure (YOU) has wrapped up FY 2025 with fourth quarter revenue of US$240.8 million and basic EPS of US$0.31, alongside trailing 12 month revenue of US$900.8 million and EPS of US$1.14 that frame the latest print in a broader earnings context. Over recent periods the company has seen quarterly revenue move from US$198.4 million in Q3 2024 to US$240.8 million in Q4 2025, while basic EPS has shifted from US$0.25 to US$0.31 across the same span...
NasdaqGS:AMPH
NasdaqGS:AMPHPharmaceuticals

FDA COPD Generic Exclusivity Might Change The Case For Investing In Amphastar Pharmaceuticals (AMPH)

In February 2026, Amphastar Pharmaceuticals received U.S. FDA approval for its Ipratropium Bromide HFA Inhalation Aerosol as a generic equivalent to Boehringer Ingelheim's Atrovent HFA, including 180 days of marketing exclusivity for COPD maintenance treatment. This short period of exclusivity offers Amphastar a time-limited window to build presence in the inhaled COPD market while supporting its broader mix of generic and proprietary products. Next, we’ll examine how the 180-day exclusivity...
NYSE:LTH
NYSE:LTHHospitality

Life Time Group Holdings (LTH) Margin Jump Tests Bullish Profitability Narratives

Life Time Group Holdings (LTH) closed out FY 2025 with Q4 revenue of US$745.1 million, basic EPS of US$0.56 and net income excluding extra items of US$123 million, set against a year in which trailing twelve month revenue reached US$3.0 billion, EPS was US$1.71 and net income was US$373.7 million. Over the past few quarters, the company has seen revenue move from US$663.3 million and EPS of US$0.18 in Q4 2024 to US$745.1 million and EPS of US$0.56 in Q4 2025. Trailing EPS stepped up from...
NasdaqCM:UFPT
NasdaqCM:UFPTMedical Equipment

UFP Technologies (UFPT) Earnings Growth Of 15.8% Tests Bearish Margin Concerns

UFP Technologies (UFPT) has wrapped up FY 2025 with Q4 revenue of US$148.9 million and basic EPS of US$2.28, framed by trailing twelve month revenue of US$602.8 million and EPS of US$8.87 that reflect earnings growth of 15.8% over the past year. The company has seen revenue move from US$504.4 million and EPS of US$7.69 on a trailing basis in Q4 2024 to US$602.8 million and EPS of US$8.87 by Q4 2025, which sets the scene for investors to weigh solid earnings expansion against a slightly softer...
NYSE:AOMR
NYSE:AOMRMortgage REITs

Angel Oak Mortgage REIT (AOMR) Quarterly EPS Swings Challenge Income Stability Narratives

Angel Oak Mortgage REIT (AOMR) has just posted its FY 2025 results, with Q4 total revenue of US$16.7 million and basic EPS of US$0.46, while trailing 12 month revenue came in at US$61.0 million and basic EPS at US$1.86, alongside reported earnings growth of 54% over the year. Over recent quarters the company has seen total revenue range from US$23.5 million and basic EPS of US$0.88 in Q1 2025, to US$5.9 million and basic EPS of US$0.03 in Q2, US$14.9 million and basic EPS of US$0.49 in Q3,...
NYSE:RRC
NYSE:RRCOil and Gas

Range Resources (RRC) Margin Expansion Reinforces Bullish Narratives After FY 2025 Earnings

Range Resources (RRC) has wrapped up FY 2025 with fourth quarter revenue of US$913.9 million and basic EPS of US$0.75, alongside net income excluding extra items of US$178.0 million, capping a year where trailing twelve month revenue reached US$3.1 billion and EPS came in at US$2.77. Over the past year the company has seen revenue move from US$2.4 billion to US$3.1 billion on a trailing basis, while net income excluding extra items has gone from US$265.0 million to US$658.0 million and basic...
NasdaqGM:ODD
NasdaqGM:ODDPersonal Products

Oddity Tech (ODD) Margin Compression Reinforces Bearish Narrative Despite FY 2025 EPS Growth

Recent Results Set Against a Shifting Earnings Outlook Oddity Tech (NasdaqGM:ODD) has wrapped up FY 2025 with fourth quarter revenue of US$152.7 million and basic EPS of US$0.10, alongside trailing twelve month revenue of US$809.8 million and EPS of US$1.95 that sit against a 9.1% year over year earnings increase and a net margin of 13.7%. Over the past year, the company has seen quarterly revenue move from US$123.6 million in Q4 2024 to US$268.1 million in Q1 2025, US$241.1 million in Q2,...
NasdaqGS:BLMN
NasdaqGS:BLMNHospitality

Bloomin' Brands (BLMN) Q4 EPS Loss Keeps Margin Concerns In Focus For Bulls And Bears

Bloomin' Brands FY 2025 earnings snapshot Bloomin' Brands (BLMN) has wrapped up FY 2025 with Q4 revenue of US$975.2 million and a basic EPS loss of US$0.14, as net income excluding extra items came in at a loss of US$12.2 million. Over the past few quarters, revenue has ranged from US$928.8 million to US$1.05 billion while EPS has swung from a profit of US$0.50 in Q1 to a loss of US$0.54 in Q3 and a smaller loss in Q4. This combination presents a mixed picture on earnings quality and...
NasdaqGS:MORN
NasdaqGS:MORNCapital Markets

Morningstar (MORN) Valuation Check After Earnings Beat Buyback And New Retirement Products

Morningstar (MORN) has been back in focus after reporting quarterly results that exceeded analyst expectations on revenue and EPS, along with new retirement products, a leadership hire in its Direct Platform business, and a completed share repurchase. See our latest analysis for Morningstar. Despite the recent earnings beat, new retirement products, and leadership changes, Morningstar’s share price performance has been weak, with a 30 day share price return of 18.38% and a 1 year total...
NYSE:PSTL
NYSE:PSTLOffice REITs

Postal Realty Trust (PSTL) Earnings Margins Strengthen Supportive Bullish Lease Narrative

Postal Realty Trust (PSTL) has just wrapped up FY 2025 with fourth quarter revenue of US$26.0 million and basic EPS of US$0.25, alongside trailing 12 month revenue of US$95.8 million and basic EPS of US$0.58 that frame the latest numbers in a fuller earnings picture. Over the past few reporting periods, the company has seen revenue move from US$21.4 million in Q4 2024 to US$26.0 million in Q4 2025, while quarterly basic EPS shifted from US$0.17 to US$0.25, setting up this result against a...
NYSE:DRI
NYSE:DRIHospitality

Darden Restaurants Earns Quality Screen Spot With Solid Valuation Support

Darden Restaurants (NYSE:DRI) has been recognized for strong operational performance and quality metrics after passing a respected quality investing screen. The recognition highlights the company’s financial discipline and effective management, drawing fresh attention from long term investors focused on business quality. Darden Restaurants, trading at $212.06, is coming off a stretch of steady share performance that may catch your eye if you track longer time frames. The stock is up 13.3%...
NasdaqGS:ABCL
NasdaqGS:ABCLLife Sciences

AbCellera Biologics (ABCL) Q4 Loss Narrows To US$0.03 EPS And Tests Bearish Narratives

AbCellera Biologics (ABCL) closed out FY 2025 with Q4 revenue of US$44.9 million and a basic EPS loss of US$0.03, alongside trailing 12 month revenue of US$75.1 million and a full year basic EPS loss of US$0.49, providing a snapshot of a business still investing heavily ahead of profitability. Over the past few quarters, the company reported revenue of US$4.2 million in Q1 2025, US$17.1 million in Q2, US$9.0 million in Q3 and US$44.9 million in Q4, while quarterly EPS losses moved from...
NasdaqCM:ESTA
NasdaqCM:ESTAMedical Equipment

How Investors Are Reacting To Establishment Labs (ESTA) Revenue Guidance And CFO Shake‑Up

In February 2026, Establishment Labs Holdings reported fourth‑quarter 2025 sales of US$64.62 million and full‑year sales of US$211.08 million, sharply reducing its net loss and issuing 2026–2027 revenue guidance that implies more than 25% annual growth alongside expectations for positive cash flow. The company also reshaped its leadership team by moving current CFO Raj Denhoy into a global strategy role and appointing experienced finance executive Cassandra “Sandra” Harris as CFO, aligning...
NYSE:AL
NYSE:ALTrade Distributors

Is It Too Late To Consider Air Lease (AL) After Strong Five Year Share Price Gains

If you are wondering whether Air Lease is still offering value at its current share price, this article will walk through what the numbers actually say about the stock. With the share price at US$64.85 and returns of 0.1% over 7 days, 0.7% over 30 days, 1.1% year to date, 36.8% over 1 year, 57.7% over 3 years and 50.1% over 5 years, many investors are asking whether expectations and valuation are now in sync. Recent news on Air Lease has focused on its role in supplying aircraft to airlines...
NYSE:HRI
NYSE:HRITrade Distributors

Herc’s 2025 Profit Squeeze After H&E Deal Raises Fresh Questions About Its Margin Strategy (HRI)

Herc Holdings Inc. reported past fourth-quarter 2025 sales of US$1,039 million and revenue of US$1,209 million, swinging from a prior-year quarterly net loss to net income of US$24 million, while full-year 2025 net income slipped to US$1 million despite higher sales and revenue. The results highlight how integrating the large H&E acquisition, with its associated costs and balance sheet impact, has lifted top-line performance but compressed overall profitability during 2025. We’ll now examine...
NYSE:AII
NYSE:AIIInsurance

American Integrity Insurance Group (AII) Margin Expansion Challenges Bearish Earnings Narratives

American Integrity Insurance Group closed FY 2025 with fourth quarter revenue of US$68.1 million and basic EPS of US$1.07, rounding out a twelve month stretch that produced total revenue of US$276.5 million and basic EPS of US$5.65. Over the past year, the company has seen revenue move from US$204.4 million to US$276.5 million and basic EPS adjust from US$309.45 to US$5.65 on a trailing twelve month basis, giving investors a detailed view of how the top and bottom lines have evolved. With net...
NYSE:FLS
NYSE:FLSMachinery

A Look At Flowserve (FLS) Valuation After Dividend Increase And Submersible Pumps Growth Tailwinds

Dividend increase and sector tailwinds put Flowserve (FLS) on income investors’ radar Flowserve (FLS) recently approved a 5% lift to its quarterly cash dividend, alongside a constructive outlook for the U.S. submersible pumps market. This combination is putting fresh attention on the stock for income focused investors. See our latest analysis for Flowserve. Those dividend and industry headlines come on top of strong share price momentum, with Flowserve’s 30 day share price return at 18.38%...
NYSE:YETI
NYSE:YETILeisure

Evaluating Yeti Holdings (YETI) After A Recent Pullback And Conflicting Valuation Signals

YETI Holdings (YETI) has been drawing attention after a recent pullback, with the share price down around 1% over the past day and about 9% over the past week. See our latest analysis for YETI Holdings. Zooming out, the recent pullback sits against a mixed picture, with a 30 day share price return of 5.81% decline, a 90 day share price return of 7.81% gain, and a 1 year total shareholder return of 19.63%. This suggests shorter term momentum has cooled while longer term holders have still seen...
NYSE:GIC
NYSE:GICTrade Distributors

Global Industrial (GIC) Earnings Growth And 5.2% Margin Challenge Long Term Skepticism

Global Industrial (GIC) has just wrapped up FY 2025 with fourth quarter revenue of US$345.6 million and basic EPS of US$0.38, capping a trailing twelve month period where earnings grew 19.4% and net margin reached 5.2%. The company has seen revenue move from US$302.3 million and EPS of US$0.27 in Q4 2024 to US$345.6 million and EPS of US$0.38 in Q4 2025, while trailing twelve month net income, excluding extraordinary items, stood at US$72 million on US$1.4 billion of revenue. With earnings...
NYSE:DE
NYSE:DEMachinery

Is It Too Late To Consider Deere (DE) After A 34% Year To Date Rally?

If you are trying to figure out whether Deere is still reasonably priced or starting to look stretched, the recent share performance gives you plenty to think about. The stock last closed at US$623.61, with returns of 5.1% over 7 days, 20.7% over 30 days, 33.6% year to date, 32.1% over 1 year, 54.9% over 3 years and 94.0% over 5 years. Recent coverage has focused on Deere's position as a key capital goods manufacturer and how its equipment and technology are tied to long term trends in...
NYSE:SEI
NYSE:SEIEnergy Services

Solaris Energy Infrastructure (SEI) Quarterly Loss Tests Bullish High‑Growth Narrative

Solaris Energy Infrastructure (SEI) has capped FY 2025 with Q4 revenue of US$179.7 million and a small EPS loss of US$0.04, set against a trailing 12 month EPS of US$0.69 on revenue of US$622.2 million and earnings growth of 95.8% over the past year. Over recent periods the company has seen revenue lift from US$96.3 million in Q4 FY 2024 to US$179.7 million in Q4 FY 2025. Quarterly EPS moved from US$0.20 to US$0.32 and US$0.30 in Q2 and Q3 FY 2025 before slipping to a modest loss in Q4,...
NYSE:ZBH
NYSE:ZBHMedical Equipment

Zimmer Biomet Showcases Robotics And Smart Implants At AAOS 2026 Event

Zimmer Biomet Holdings (NYSE:ZBH) plans to showcase advanced orthopedic technologies at AAOS 2026. The lineup includes FDA-cleared robotics, AI-supported navigation systems, smart implants, and fresh clinical data. Chief Movement Officer Arnold Schwarzenegger is scheduled to appear as a guest speaker at the event. Zimmer Biomet is a major player in musculoskeletal healthcare, with a portfolio that spans joint replacement, sports medicine, and related technologies. The AAOS 2026 announcement...